JP Morgan Chase’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $342M | Buy |
385,900
+11,500
| +3% | +$11.7M | 0.02% | 508 |
|
|
2025
Q4 | $402M | Buy |
374,400
+45,100
| +14% | +$43.1M | 0.03% | 458 |
|
|
2025
Q3 | $251M | Buy |
329,300
+72,900
| +28% | +$54.2M | 0.02% | 617 |
|
|
2025
Q2 | $200M | Buy |
256,400
+67,200
| +36% | +$52.2M | 0.01% | 684 |
|
|
2025
Q1 | $156M | Sell |
189,200
-163,900
| -46% | -$136M | 0.01% | 757 |
|
|
2024
Q4 | $273M | Buy |
353,100
+40,700
| +13% | +$33.7M | 0.02% | 559 |
|
|
2024
Q3 | $277M | Sell |
312,400
-127,600
| -29% | -$115M | 0.02% | 571 |
|
|
2024
Q2 | $398M | Buy |
440,000
+43,100
| +11% | +$34.5M | 0.03% | 420 |
|
|
2024
Q1 | $309M | Buy |
396,900
+78,000
| +24% | +$55.5M | 0.03% | 518 |
|
|
2023
Q4 | $186M | Sell |
318,900
-37,600
| -11% | -$21.9M | 0.02% | 633 |
|
|
2023
Q3 | $191M | Buy |
356,500
+332,200
| +1,367% | +$171M | 0.02% | 562 |
|
|
2023
Q2 | $11.4M | Sell |
24,300
-278,000
| -92% | -$117M | ﹤0.01% | 2188 |
|
|
2023
Q1 | $104M | Buy |
302,300
+245,000
| +428% | +$82.6M | 0.01% | 779 |
|
|
2022
Q4 | $21M | Sell |
57,300
-68,400
| -54% | -$24.3M | ﹤0.01% | 1636 |
|
|
2022
Q3 | $40.6M | Buy |
125,700
+3,000
| +2% | +$951K | 0.01% | 1148 |
|
|
2022
Q2 | $39.8M | Sell |
122,700
-185,400
| -60% | -$55.7M | 0.01% | 1171 |
|
|
2022
Q1 | $88.2M | Sell |
308,100
-300,000
| -49% | -$77.2M | 0.01% | 891 |
|
|
2021
Q4 | $168M | Buy |
608,100
+359,800
| +145% | +$91.2M | 0.02% | 638 |
|
|
2021
Q3 | $57.4M | Buy |
248,300
+220,300
| +787% | +$54.4M | 0.01% | 1108 |
|
|
2021
Q2 | $6.43M | Buy |
28,000
+3,500
| +14% | +$703K | ﹤0.01% | 2832 |
|
|
2021
Q1 | $4.58M | Buy |
24,500
+20,600
| +528% | +$4.03M | ﹤0.01% | 3041 |
|
|
2020
Q4 | $658K | Sell |
3,900
-38,500
| -91% | -$5.75M | ﹤0.01% | 4218 |
|
|
2020
Q3 | $6.2M | Buy |
42,400
+38,500
| +987% | +$5.96M | ﹤0.01% | 2388 |
|
|
2020
Q2 | $640K | Sell |
3,900
-132,100
| -97% | -$20.3M | ﹤0.01% | 3742 |
|
|
2020
Q1 | $18.9M | Buy |
136,000
+60,000
| +79% | +$8.24M | ﹤0.01% | 1294 |
|
|
2019
Q4 | $9.99M | Sell |
76,000
-43,000
| -36% | -$4.98M | ﹤0.01% | 2118 |
|
|
2019
Q3 | $13.3M | Buy |
119,000
+18,000
| +18% | +$2M | ﹤0.01% | 1903 |
|
|
2019
Q2 | $11.3M | Sell |
101,000
-2,400
| -2% | -$283K | ﹤0.01% | 2021 |
|
|
2019
Q1 | $13.4M | Sell |
103,400
-38,400
| -27% | -$4.67M | ﹤0.01% | 1813 |
|
|
2018
Q4 | $16.4M | Buy |
141,800
+16,600
| +13% | +$1.85M | ﹤0.01% | 1626 |
|
|
2018
Q3 | $13.4M | Buy |
125,200
+2,500
| +2% | +$250K | ﹤0.01% | 1961 |
|
|
2018
Q2 | $10.5M | Buy |
122,700
+17,100
| +16% | +$1.4M | ﹤0.01% | 2107 |
|
|
2018
Q1 | $8.17M | Sell |
105,600
-29,500
| -22% | -$2.37M | ﹤0.01% | 2172 |
|
|
2017
Q4 | $11.4M | Buy |
135,100
+87,600
| +184% | +$7.45M | ﹤0.01% | 2019 |
|
|
2017
Q3 | $4.04M | Buy |
47,500
+45,200
| +1,965% | +$3.71M | ﹤0.01% | 2715 |
|
|
2017
Q2 | $189K | Sell |
2,300
-690
| -23% | -$56.3K | ﹤0.01% | 3993 |
|
|
2017
Q1 | $251K | Sell |
2,990
-420,600
| -99% | -$33.7M | ﹤0.01% | 3989 |
|
|
2016
Q4 | $31.2M | Buy |
423,590
+272,390
| +180% | +$20.3M | 0.01% | 1185 |
|
|
2016
Q3 | $12.1M | Buy |
+151,200
| New | +$12.1M | ﹤0.01% | 1660 |
|
|
2016
Q2 | – | Sell |
-3,232
| Closed | -$232K | – | 4875 |
|
|
2016
Q1 | $232K | Buy |
3,232
+3,032
| +1,516% | +$229K | ﹤0.01% | 3566 |
|
|
2015
Q4 | $17K | Hold |
200
| – | – | ﹤0.01% | 4103 |
|
|
2015
Q3 | $17K | Sell |
200
-29,800
| -99% | -$2.52M | ﹤0.01% | 3842 |
|
|
2015
Q2 | $2.5M | Buy |
30,000
+27,000
| +900% | +$2.06M | ﹤0.01% | 2777 |
|
|
2015
Q1 | $218K | Sell |
3,000
-20,200
| -87% | -$1.44M | ﹤0.01% | 3798 |
|
|
2014
Q4 | $1.6M | Sell |
23,200
-20,900
| -47% | -$1.41M | ﹤0.01% | 3086 |
|
|
2014
Q3 | $2.86M | Buy |
+44,100
| New | +$2.79M | ﹤0.01% | 2703 |
|
|
2014
Q1 | – | Sell |
-3,200
| Closed | -$163K | – | 3769 |
|
|
2013
Q4 | $163K | Sell |
3,200
-6,600
| -67% | -$331K | ﹤0.01% | 3843 |
|
|
2013
Q3 | $493K | Sell |
9,800
-109,800
| -92% | -$5.75M | ﹤0.01% | 3640 |
|
|
2013
Q2 | $5.88M | Buy |
+119,600
| New | +$6.51M | ﹤0.01% | 2026 |
|
Other funds holding LLY
VCM
VPM
JP Morgan Chase's LLY Position: Q1 2026 in Review
JP Morgan Chase increased its Eli Lilly (LLY) stake by 5.4% in Q1 2026, buying an estimated $710M and bringing the position to 13,698,491 shares worth $12.1B. The position accounts for 0.78% of the portfolio, ranked #18.
JP Morgan Chase first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. The position peaked at $17.1B in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- JP Morgan Chase held 13,698,491 shares of Eli Lilly worth $12.1B as of Q1 2026.
- JP Morgan Chase bought 700,545 Eli Lilly shares in Q1 2026, an estimated $710M.
- Eli Lilly made up 0.78% of JP Morgan Chase's portfolio in Q1 2026, its #18 holding.
- JP Morgan Chase first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
- JP Morgan Chase's Eli Lilly position peaked at $17.1B in Q2 2024.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.